In Case You Missed It: Baltimore Running Festival photos

Topics

Takeda Pharmaceutical Company Limited
FDA approves a new antidepressant: Brintellix
FDA approves a new antidepressant: Brintellix

The Food and Drug Administration late Monday approved a new antidepressant medication that is a novel variant on the selective serotonin reuptake inhibitors, or SSRIs, that have become the mainstay of depression treatment. The drug, whose generic chemical name is vortioxetine, is to be marketed under the commercial name Brintellix. Brintellix received the agency's approval without deliberation by a science advisory panel, a public review of an investigative drug's safety and effectiveness. In announcing its decision, the FDA said the new medication was found "effective in treating depression" in six clinical trials that compared outcomes in subjects taking the drug...

Loading